Residents Executive Committee

RSS Residents Executive Committee

Julie Jiang

Julie Jiang, MD, PhD


Julie Jiang is a radiation oncology resident at Montefiore Medical Center. She completed a double major in Biomedical Engineering and Applied Mathematics & Statistics at the Johns Hopkins University.

Dr. Jiang then went on to obtain an MD and PhD in Biomedical Sciences at Albert Einstein College of Medicine. Dr. Jiang has given oral presentations at conferences including ESTRO and Association for Clinical and Translational Science. She has published in several journals, such as Oral Oncology and Journal of Gastrointestinal Oncology.

Bhargava Chitti

Bhargava Chitti, MD


I am a radiation oncology resident at Northwell Health in Queens, NY. I graduated from The George Washington University with a BS in Biological Sciences, and subsequently went on to obtain my medical degree at the George Washington University School of Medicine. I completed my transitional year internship at Bronxcare Hospital. I have given several poster presentations at ASTRO, an oral presentation at the RSNA annual meeting, and have published in a number of journals, including Genes and Cancer, and Cureus. I am really passionate about mentorship and am proud to have planned the first annual RSS Mentorship Reception with RSS founding partner Kristine Gagliardi and board member Dr. Helen Shih. Some of my other interests include mentoring a 6th grader as part of Apex For Youth, running marathons, and making bubble tea for friends and family!

Raj Singh

Raj Singh, MD


Raj Singh, M.D., is Chief Resident Physician in Radiation Oncology at Virginia Commonwealth University Health System in Richmond, VA. His undergraduate studies were completed at Duke University, where he graduated with a Bachelor's of Science in Economics with Distinction. He received his M.D. from Marshall University Joan C. Edwards School of Medicine in Huntington, WV, and completed his Transitional Year Internship at Mather Hospital (Northwell Health System) in Port Jefferson, NY. He has research interests in optimizing patient selection for local therapy with SBRT for oligometastatic disease (particularly in the pediatric setting), SRS for benign/functional disorders and brain metastases, and personalization of therapy for HPV-associated oropharyngeal squamous cell carcinomas.

Raj has been actively involved in the RSS since 2015 as a medical student having worked extensively with the RSSearch Patient Registry on SRS for trigeminal neuralgia, recurrent glioblastoma, and vestibular schwannomas as well as SBRT for non-resectable pancreatic cancers, locally recurrent head and neck cancers, spinal metastases, and histology-specific studies on metastatic head and neck cancers and renal cell carcinomas.

Benjamin Schrank

Benjamin Schrank, MD, PhD

Executive Member

Dr. Schrank is a resident physician in the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center. He completed a transitional year internship at Memorial Sloan Kettering Cancer Center, and he holds an MD and PhD from Columbia University in New York. His graduate work focused on DNA repair, was published in Nature, and he continues to study the link between genome instability and immune activation in the laboratory. His clinical research interests include optimizing dose escalation strategies to overcome the intrinsic tumor radioresistance using spine stereotactic radiosurgery.

Karin Skalina

Karin Skalina, MD, PhD

Dr. Skalina is a radiation oncology resident at Montefiore Medical Center in Bronx, NY. She earned a Bachelor of Science degree in Chemical Engineering magna cum laude with highest thesis honors from Tufts University before entering the MD/PhD program at Albert Einstein College of Medicine, Bronx, NY. Her graduate work was on the immunological effects of focused ultrasound therapy in combination with radiation therapy under the direction of Dr. Chandan Guha. Her research interests involve modulating the immune system with focal therapies, including radiation and focused ultrasound, to enhance anti-tumor immunity.